{"id":5350,"date":"2016-08-17T19:50:43","date_gmt":"2016-08-17T19:50:43","guid":{"rendered":"https:\/\/lmcca.wpengine.com\/?p=5350"},"modified":"2016-08-17T19:56:02","modified_gmt":"2016-08-17T19:56:02","slug":"sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/www.lmc.ca\/ur\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","title":{"rendered":"\u0633\u0646\u0648\u0641\u06cc \u06a9\u0648 \u0679\u0627\u0626\u067e 2 \u0630\u06cc\u0627\u0628\u06cc\u0637\u0633 \u0648\u0627\u0644\u06d2 \u0628\u0627\u0644\u063a\u0648\u06ba \u06a9\u06d2 \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0644\u06cc\u06d2 AdlyxinTM \u06a9\u06cc FDA \u06a9\u06cc \u0645\u0646\u0638\u0648\u0631\u06cc \u0645\u0644 \u06af\u0626\u06cc"},"content":{"rendered":"

\u0633\u06cc\u0646\u0648\u0641\u06cc<\/a> 28 \u062c\u0648\u0644\u0627\u0626\u06cc \u06a9\u0648 \u0627\u0639\u0644\u0627\u0646 \u06a9\u06cc\u0627 \u06af\u06cc\u0627 \u06a9\u06c1 \u0627\u0645\u0631\u06cc\u06a9\u06cc \u0641\u0648\u0688 \u0627\u06cc\u0646\u0688 \u0688\u0631\u06af \u0627\u06cc\u0688\u0645\u0646\u0633\u0679\u0631\u06cc\u0634\u0646 (FDA) \u0646\u06d2 \u0627\u06cc\u0688\u0644\u06a9\u0633\u0646 \u06a9\u06cc \u0645\u0646\u0638\u0648\u0631\u06cc \u062f\u06d2 \u062f\u06cc\u0679\u06cc \u0627\u06cc\u0645<\/sup> (\u0644\u0650\u06a9\u0633\u06cc\u0633\u06cc\u0646\u0627\u0679\u0627\u0626\u0688)\u060c \u062c\u0648 \u06a9\u06c1 \u0627\u06cc\u06a9 \u0628\u0627\u0631 \u0631\u0648\u0632\u0627\u0646\u06c1 \u06a9\u06be\u0627\u0646\u06d2 \u06a9\u06d2 \u0648\u0642\u062a \u062f\u06cc\u0627 \u062c\u0627\u0646\u06d2 \u0648\u0627\u0644\u0627 \u062c\u06cc \u0627\u06cc\u0644 \u067e\u06cc-1 \u0631\u06cc\u0633\u06cc\u067e\u0679\u0631 \u0627\u06cc\u06af\u0648\u0646\u0633\u0679 \u0627\u0646\u062c\u06cc\u06a9\u0634\u0646 \u06c1\u06d2\u060c \u062c\u0648 2 \u0642\u0633\u0645 \u06a9\u06d2 \u0630\u06cc\u0627\u0628\u06cc\u0637\u0633 \u0648\u0627\u0644\u06d2 \u0628\u0627\u0644\u063a\u0648\u06ba \u06a9\u06d2 \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0644\u06cc\u06d2 \u062e\u0648\u0631\u0627\u06a9 \u0627\u0648\u0631 \u0648\u0631\u0632\u0634 \u06a9\u06d2 \u0633\u0627\u062a\u06be \u0628\u0637\u0648\u0631 \u0645\u0639\u0627\u0648\u0646 \u0627\u0633\u062a\u0639\u0645\u0627\u0644 \u06a9\u06d2 \u0644\u06cc\u06d2 \u0645\u0646\u0638\u0648\u0631 \u0634\u062f\u06c1 \u06c1\u06d2\u06d4.<\/p>\n

\u201c\u0627\u06cc\u0688\u0644\u06a9\u0633\u0646 \u06a9\u06cc \u0645\u0646\u0638\u0648\u0631\u06cc \u0630\u06cc\u0627\u0628\u06cc\u0637\u0633 \u06a9\u06d2 \u0645\u0631\u06cc\u0636\u0648\u06ba \u06a9\u0648 \u0627\u0646 \u06a9\u06d2 \u062e\u0648\u0646 \u0645\u06cc\u06ba \u06af\u0644\u0648\u06a9\u0648\u0632 (HbA1c) \u06a9\u06d2 \u0645\u0642\u0631\u0631\u06c1 \u0627\u06c1\u062f\u0627\u0641 \u06a9\u0648 \u062d\u0627\u0635\u0644 \u06a9\u0631\u0646\u06d2 \u0627\u0648\u0631 \u0628\u0631\u0642\u0631\u0627\u0631 \u0631\u06a9\u06be\u0646\u06d2 \u0645\u06cc\u06ba \u062f\u0631\u067e\u06cc\u0634 \u0686\u06cc\u0644\u0646\u062c\u0648\u06ba \u0633\u06d2 \u0646\u0645\u0679\u0646\u06d2 \u06a9\u06d2 \u06c1\u0645\u0627\u0631\u06d2 \u062c\u0627\u0631\u06cc \u0639\u0632\u0645 \u06a9\u06cc \u062a\u0648\u062b\u06cc\u0642 \u06a9\u0631\u062a\u06cc \u06c1\u06d2\u060c\u201d<\/em> \u067e\u06cc\u0679\u0631 \u06af\u06cc\u0646\u0679\u0631\u060c \u0627\u06cc\u06af\u0632\u06cc\u06a9\u0679\u0648 \u0648\u0627\u0626\u0633 \u067e\u0631\u06cc\u0630\u06cc\u0688\u0646\u0679\u060c \u06c1\u06cc\u0688\u060c \u06af\u0644\u0648\u0628\u0644 \u0688\u0627\u0626\u06cc\u0628\u06cc\u0679\u06cc\u0632 \u0627\u06cc\u0646\u0688 \u06a9\u0627\u0631\u0688\u06cc\u0648\u0648\u0627\u0633\u06a9\u0648\u0644\u0631 \u0628\u0632\u0646\u0633 \u06cc\u0648\u0646\u0679\u060c \u0633\u06cc\u0646\u0648\u0641\u06cc \u0646\u06d2 \u06a9\u06c1\u0627\u06d4 \u201c\u06c1\u0645 \u0627\u0633 \u0645\u0646\u0638\u0648\u0631\u06cc \u0633\u06d2 \u062e\u0648\u0634 \u06c1\u06cc\u06ba\u060c \u06a9\u06cc\u0648\u0646\u06a9\u06c1 \u06cc\u06c1 \u06c1\u0645\u06cc\u06ba \u0627\u06cc\u0633\u06d2 \u0645\u0631\u06cc\u0636\u0648\u06ba \u06a9\u06cc \u0645\u062f\u062f \u062c\u0627\u0631\u06cc \u0631\u06a9\u06be\u0646\u06d2 \u06a9\u0627 \u0645\u0648\u0642\u0639 \u0641\u0631\u0627\u06c1\u0645 \u06a9\u0631\u062a\u0627 \u06c1\u06d2 \u062c\u0646 \u06a9\u0627 \u0639\u0644\u0627\u062c \u0628\u06cc\u0633\u0644 \u0627\u0646\u0633\u0648\u0644\u06cc\u0646 \u0633\u06d2 \u06c1\u0648 \u0631\u06c1\u0627 \u06c1\u06d2 \u0627\u0648\u0631 \u062c\u0648 \u0628\u06d2 \u0642\u0627\u0628\u0648 \u06c1\u06cc\u06ba\u06d4.<\/p>\n

\u0627\u06cc\u0688\u0644\u06a9\u0633\u06cc\u0646 \u06a9\u06cc \u0645\u0646\u0638\u0648\u0631\u06cc\u0679\u06cc \u0627\u06cc\u0645<\/sup> \u0627\u06cc\u0641 \u0688\u06cc \u0627\u06d2 \u06a9\u06d2 \u06af\u06cc\u0679 \u06af\u0648\u0644 \u06a9\u0644\u06cc\u0646\u06cc\u06a9\u0644 \u067e\u0631\u0648\u06af\u0631\u0627\u0645 \u06a9\u06d2 \u0646\u062a\u0627\u0626\u062c \u0627\u0648\u0631 \u0627\u06cc\u0644\u06cc\u06aa\u0633\u0627 \u0679\u0631\u0627\u0626\u0644 \u06a9\u06d2 \u0646\u062a\u0627\u0626\u062c \u06a9\u06d2 \u062c\u0627\u0626\u0632\u06d2 \u067e\u0631 \u0645\u0628\u0646\u06cc \u062a\u06be\u0627\u060c \u062c\u0633 \u0646\u06d2 \u06a9\u0627\u0645\u06cc\u0627\u0628\u06cc \u06a9\u06d2 \u0633\u0627\u062a\u06be \u0633\u06cc \u0648\u06cc \u0633\u06cc\u0641\u0679\u06cc \u06a9\u0648 \u062b\u0627\u0628\u062a \u06a9\u0631\u0646\u06d2 \u06a9\u06d2 \u0644\u06cc\u06d2 \u0627\u06cc\u0641 \u0688\u06cc \u0627\u06d2 \u06a9\u06cc \u062f\u0631\u062e\u0648\u0627\u0633\u062a \u06a9\u0648 \u067e\u0648\u0631\u0627 \u06a9\u06cc\u0627\u06d4 \u06af\u06cc\u0679 \u06af\u0648\u0644 \u06a9\u0644\u06cc\u0646\u06cc\u06a9\u0644 \u067e\u0631\u0648\u06af\u0631\u0627\u0645\u060c \u062c\u0633 \u0645\u06cc\u06ba \u062f\u0646\u06cc\u0627 \u0628\u06be\u0631 \u0645\u06cc\u06ba \u0679\u0627\u0626\u067e 2 \u0630\u06cc\u0627\u0628\u06cc\u0637\u0633 \u06a9\u06d2 5,000 \u0633\u06d2 \u0632\u06cc\u0627\u062f\u06c1 \u0628\u0627\u0644\u063a \u0627\u0641\u0631\u0627\u062f \u067e\u0631 \u0645\u0634\u062a\u0645\u0644 13 \u06a9\u0644\u06cc\u0646\u06cc\u06a9\u0644 \u0679\u0631\u0627\u0626\u0644\u0632 \u0634\u0627\u0645\u0644 \u062a\u06be\u06d2\u060c \u0646\u06d2 \u0679\u0627\u0626\u067e 2 \u0630\u06cc\u0627\u0628\u06cc\u0637\u0633 \u06a9\u06d2 \u0628\u0627\u0644\u063a\u0648\u06ba \u0645\u06cc\u06ba \u0644\u06a9\u0633\u06cc\u0646\u0627\u062a\u0627\u0626\u0688 \u06a9\u06cc \u062d\u0641\u0627\u0638\u062a \u0627\u0648\u0631 \u062a\u0627\u062b\u06cc\u0631 \u06a9\u0627 \u062c\u0627\u0626\u0632\u06c1 \u0644\u06cc\u0627\u06d4 \u06af\u06cc\u0679 \u06af\u0648\u0644 \u067e\u0631\u0648\u06af\u0631\u0627\u0645 \u06a9\u06d2 \u062a\u0645\u0627\u0645 \u0645\u0637\u0627\u0644\u0639\u0627\u062a \u0646\u06d2 \u06a9\u0627\u0645\u06cc\u0627\u0628\u06cc \u06a9\u06d2 \u0633\u0627\u062a\u06be HbA1c \u0645\u06cc\u06ba \u06a9\u0645\u06cc \u06a9\u06d2 \u0628\u0646\u06cc\u0627\u062f\u06cc \u0627\u0641\u0627\u062f\u06cc\u062a \u06a9\u06d2 \u0627\u062e\u062a\u062a\u0627\u0645 \u06a9\u0648 \u067e\u0648\u0631\u0627 \u06a9\u06cc\u0627\u06d4 \u0627\u0688\u0644\u06a9\u0633\u0646 \u06a9\u06d2 \u0644\u06cc\u06d2 \u0631\u067e\u0648\u0631\u0679 \u06a9\u06cc\u06d2 \u06af\u0626\u06d2 \u0633\u0628 \u0633\u06d2 \u0639\u0627\u0645 \u0645\u0636\u0631 \u0627\u062b\u0631\u0627\u062a \u0645\u06cc\u06ba \u0645\u062a\u0644\u06cc\u060c \u06c1\u0627\u0626\u067e\u0648\u06af\u0644\u06cc\u0633\u06cc\u0645\u06cc\u0627 \u0627\u0648\u0631 \u0627\u0644\u0679\u06cc \u0634\u0627\u0645\u0644 \u062a\u06be\u06d2\u06d4.<\/p>\n

Adlyxin \u0627\u06cc\u06a9 \u0688\u0633\u067e\u0648\u0632\u0627\u06cc\u0628\u0644 \u067e\u0631\u06cc-\u0641\u0650\u0644\u0688 \u0642\u0644\u0645 \u0645\u06cc\u06ba 20 \u0645\u0627\u0626\u06cc\u06a9\u0631\u0648\u06af\u0631\u0627\u0645 \u06a9\u06cc \u0648\u0627\u062d\u062f \u062e\u0648\u0631\u0627\u06a9 \u06a9\u06d2 \u0637\u0648\u0631 \u067e\u0631 \u062f\u0633\u062a\u06cc\u0627\u0628 \u06c1\u0648\u06af\u0627\u06d4 \u0645\u0631\u06cc\u0636\u0648\u06ba \u06a9\u0648 10 \u0645\u0627\u0626\u06cc\u06a9\u0631\u0648\u06af\u0631\u0627\u0645 \u06a9\u06cc \u0648\u0627\u062d\u062f \u062e\u0648\u0631\u0627\u06a9 \u06a9\u06d2 \u0633\u0627\u062a\u06be \u0627\u06cc\u06a9 \u0688\u0633\u067e\u0648\u0632\u0627\u06cc\u0628\u0644 \u067e\u0631\u06cc-\u0641\u0650\u0644\u0688 \u0642\u0644\u0645 \u0628\u06be\u06cc \u0645\u0644\u06d2 \u06af\u06cc \u062c\u0633\u06d2 \u0627\u0646\u06c1\u06cc\u06ba 14 \u062f\u0646 \u062a\u06a9 \u0631\u0648\u0632\u0627\u0646\u06c1 \u0627\u06cc\u06a9 \u0628\u0627\u0631 \u0634\u0631\u0648\u0639 \u06a9\u0631\u0646\u0627 \u0686\u0627\u06c1\u06cc\u06d2\u06d4 15 \u0648\u06cc\u06ba \u062f\u0646\u060c \u0645\u0631\u06cc\u0636 \u062e\u0648\u0631\u0627\u06a9 \u06a9\u0648 \u0631\u0648\u0632\u0627\u0646\u06c1 \u0627\u06cc\u06a9 \u0628\u0627\u0631 20 \u0645\u0627\u0626\u06cc\u06a9\u0631\u0648\u06af\u0631\u0627\u0645 \u062a\u06a9 \u0628\u0691\u06be\u0627 \u062f\u06cc\u06ba \u06af\u06d2\u06d4.<\/p>\n

\u0645\u06a9\u0645\u0644 \u0645\u0636\u0645\u0648\u0646 \u06a9\u06d2 \u0644\u06cc\u06d2\u060c \u0628\u0631\u0627\u06c1 \u06a9\u0631\u0645 \u06a9\u0644\u06a9 \u06a9\u0631\u06cc\u06ba \u06cc\u06c1\u0627\u06ba<\/a><\/p>\n

\u0627\u06cc\u0644 \u0627\u06cc\u0645 \u0633\u06cc \u0630\u06cc\u0627\u0628\u06cc\u0637\u0633 \u0627\u0648\u0631 \u0627\u06cc\u0646\u0688\u0648 \u06a9\u0631\u06cc\u0646\u0648\u0644\u0648\u062c\u06cc<\/a> \u0627\u06cc\u0688\u0644\u06cc\u062e\u0633\u0646 \u06a9\u06cc \u0645\u0646\u0638\u0648\u0631\u06cc \u06a9\u06d2 \u0639\u0645\u0644 \u06a9\u0627 \u062d\u0635\u06c1 \u0628\u0646\u0646\u06d2 \u0627\u0648\u0631 \u0627\u0646 \u06a9\u0644\u06cc\u0646\u06cc\u06a9\u0644 \u0679\u0631\u0627\u0626\u0644\u0632 \u0645\u06cc\u06ba \u062d\u0635\u06c1 \u0644\u06cc\u0646\u06d2 \u067e\u0631 \u0641\u062e\u0631 \u06c1\u06d2\u06d4\u0679\u06cc \u0627\u06cc\u0645<\/sup> (\u0644\u0650\u06a9\u0633\u0650\u06cc\u0632\u06cc\u0646\u0650\u0679\u0627\u0626\u0688) \u06c1\u0645\u0627\u0631\u06d2 \u06a9\u06cc\u0646\u06cc\u0688\u0627 \u06a9\u06d2 \u06a9\u0644\u06cc\u0646\u06a9\u0633 \u0645\u06cc\u06ba\u06d4 \u06a9\u0644\u06cc\u0646\u06cc\u06a9\u0644 \u0631\u06cc\u0633\u0631\u0686 \u0627\u062f\u0648\u06cc\u0627\u062a \u06a9\u06cc \u0645\u0646\u0638\u0648\u0631\u06cc \u06a9\u06d2 \u0639\u0645\u0644 \u06a9\u0627 \u0627\u06cc\u06a9 \u0644\u0627\u0632\u0645\u06cc \u062d\u0635\u06c1 \u06c1\u06d2 - \u0627\u06af\u0631 \u0622\u067e \u062c\u06cc\u0633\u06d2 \u0627\u0641\u0631\u0627\u062f \u0646\u06c1 \u06c1\u0648\u062a\u06d2\u060c \u062a\u0648 \u06cc\u06c1 \u0627\u062f\u0648\u06cc\u0627\u062a \u0645\u0646\u0638\u0648\u0631 \u06cc\u0627 \u0645\u0645\u06a9\u0646 \u0628\u06be\u06cc \u0646\u06c1 \u06c1\u0648\u062a\u06cc\u06ba!<\/h3>\n

\u062a\u062d\u0642\u06cc\u0642 \u06a9\u06d2 \u0644\u06cc\u06d2 \u0622\u067e \u062c\u0648 \u06a9\u0686\u06be \u0628\u06be\u06cc \u06a9\u0631\u062a\u06d2 \u06c1\u06cc\u06ba\u060c \u0627\u0633 \u06a9\u06d2 \u0644\u06cc\u06d2 \u0622\u067e \u06a9\u0627 \u0634\u06a9\u0631\u06cc\u06c1!<\/h3>\n

 <\/p>\n

\u06a9\u06cc\u0627 \u0622\u067e \u0645\u0633\u062a\u0642\u0628\u0644 \u0645\u06cc\u06ba \u0679\u0627\u0626\u067e 2 \u0630\u06cc\u0627\u0628\u06cc\u0637\u0633 \u067e\u0631 \u062a\u062d\u0642\u06cc\u0642 \u0645\u06cc\u06ba \u062d\u0635\u06c1 \u0644\u06cc\u0646\u06d2 \u0645\u06cc\u06ba \u062f\u0644\u0686\u0633\u067e\u06cc \u0631\u06a9\u06be\u062a\u06d2 \u06c1\u06cc\u06ba\u061f
\n\u062f\u0648\u0631\u06c1 www.improvinghealth.ca\u00a0<\/a>\u0645\u0632\u06cc\u062f \u062c\u0627\u0646\u0646\u06d2 \u06a9\u06d2 \u0644\u06cc\u06d2 \u0632\u06cc\u0631\u0650 \u0645\u0637\u0627\u0644\u0639\u06c1 \u062a\u062d\u0642\u06cc\u0642\u0627\u062a<\/a> \u062c\u0633 \u06a9\u06d2 \u0644\u06cc\u06d2 \u06c1\u0645 \u0628\u06be\u0631\u062a\u06cc \u06a9\u0631 \u0631\u06c1\u06d2 \u06c1\u06cc\u06ba!\u00a0<\/em><\/h3>","protected":false},"excerpt":{"rendered":"

Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. \u201cThe approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people […]<\/p>\n","protected":false},"author":25,"featured_media":5352,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","two_page_speed":[],"footnotes":""},"categories":[163],"tags":[156,155,83,112,161,160,159,124,162,154,158,157],"class_list":["post-5350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-adlyxin","tag-adlyxintm","tag-diabetes-research","tag-diabetes-specialists","tag-elixa-trial","tag-getgoal","tag-getgoal-clinical-program","tag-lmc-diabetes","tag-lmc-diabetes-endocrinology","tag-sanofi","tag-t2-diabetes","tag-type-2-diabetes"],"yoast_head":"\nSanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lmc.ca\/ur\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes\" \/>\n<meta property=\"og:description\" content=\"Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. \u201cThe approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lmc.ca\/ur\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"LMC Healthcare: Helping You Understand and Control your Diabetes\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LMCDiabetesandEndocrinology\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-17T19:50:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-08-17T19:56:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1811\" \/>\n\t<meta property=\"og:image:height\" content=\"2714\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"LMC Healthcare\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lmc_diabetes\" \/>\n<meta name=\"twitter:site\" content=\"@lmc_diabetes\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"LMC Healthcare\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u0645\u0646\u0679\u0633\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\"},\"author\":{\"name\":\"LMC Healthcare\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#\\\/schema\\\/person\\\/0d459c76f19eec906969bebe87612783\"},\"headline\":\"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes\",\"datePublished\":\"2016-08-17T19:50:43+00:00\",\"dateModified\":\"2016-08-17T19:56:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\"},\"wordCount\":355,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.lmc.ca\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/iStock_000014930955Large.jpg\",\"keywords\":[\"Adlyxin\",\"AdlyxinTM\",\"diabetes research\",\"diabetes specialists\",\"elixa trial\",\"getgoal\",\"getgoal clinical program\",\"lmc diabetes\",\"lmc diabetes & endocrinology\",\"sanofi\",\"t2 diabetes\",\"type 2 diabetes\"],\"articleSection\":[\"News\"],\"inLanguage\":\"ur\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\",\"url\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\",\"name\":\"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.lmc.ca\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/iStock_000014930955Large.jpg\",\"datePublished\":\"2016-08-17T19:50:43+00:00\",\"dateModified\":\"2016-08-17T19:56:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#\\\/schema\\\/person\\\/0d459c76f19eec906969bebe87612783\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#breadcrumb\"},\"inLanguage\":\"ur\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ur\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.lmc.ca\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/iStock_000014930955Large.jpg\",\"contentUrl\":\"https:\\\/\\\/www.lmc.ca\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/iStock_000014930955Large.jpg\",\"width\":1811,\"height\":2714,\"caption\":\"SONY DSC\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.lmc.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.lmc.ca\\\/\",\"name\":\"LMC Healthcare: Helping You Understand and Control your Diabetes\",\"description\":\"Consulting Design Engineers\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.lmc.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ur\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#\\\/schema\\\/person\\\/0d459c76f19eec906969bebe87612783\",\"name\":\"LMC Healthcare\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ur\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g\",\"caption\":\"LMC Healthcare\"},\"url\":\"https:\\\/\\\/www.lmc.ca\\\/ur\\\/author\\\/andrea\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lmc.ca\/ur\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","og_locale":"en_US","og_type":"article","og_title":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes","og_description":"Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. \u201cThe approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people […]","og_url":"https:\/\/www.lmc.ca\/ur\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","og_site_name":"LMC Healthcare: Helping You Understand and Control your Diabetes","article_publisher":"https:\/\/www.facebook.com\/LMCDiabetesandEndocrinology\/","article_published_time":"2016-08-17T19:50:43+00:00","article_modified_time":"2016-08-17T19:56:02+00:00","og_image":[{"width":1811,"height":2714,"url":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","type":"image\/jpeg"}],"author":"LMC Healthcare","twitter_card":"summary_large_image","twitter_creator":"@lmc_diabetes","twitter_site":"@lmc_diabetes","twitter_misc":{"Written by":"LMC Healthcare","Est. reading time":"2 \u0645\u0646\u0679\u0633"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#article","isPartOf":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/"},"author":{"name":"LMC Healthcare","@id":"https:\/\/www.lmc.ca\/#\/schema\/person\/0d459c76f19eec906969bebe87612783"},"headline":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes","datePublished":"2016-08-17T19:50:43+00:00","dateModified":"2016-08-17T19:56:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/"},"wordCount":355,"commentCount":0,"image":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","keywords":["Adlyxin","AdlyxinTM","diabetes research","diabetes specialists","elixa trial","getgoal","getgoal clinical program","lmc diabetes","lmc diabetes & endocrinology","sanofi","t2 diabetes","type 2 diabetes"],"articleSection":["News"],"inLanguage":"ur","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","url":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","name":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes","isPartOf":{"@id":"https:\/\/www.lmc.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","datePublished":"2016-08-17T19:50:43+00:00","dateModified":"2016-08-17T19:56:02+00:00","author":{"@id":"https:\/\/www.lmc.ca\/#\/schema\/person\/0d459c76f19eec906969bebe87612783"},"breadcrumb":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#breadcrumb"},"inLanguage":"ur","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"ur","@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#primaryimage","url":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","contentUrl":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","width":1811,"height":2714,"caption":"SONY DSC"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lmc.ca\/"},{"@type":"ListItem","position":2,"name":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes"}]},{"@type":"WebSite","@id":"https:\/\/www.lmc.ca\/#website","url":"https:\/\/www.lmc.ca\/","name":"LMC Healthcare: Helping You Understand and Control your Diabetes","description":"\u06a9\u0646\u0633\u0644\u0679\u0646\u06af \u0688\u06cc\u0632\u0627\u0626\u0646 \u0627\u0646\u062c\u06cc\u0646\u0626\u0631\u0632","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lmc.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ur"},{"@type":"Person","@id":"https:\/\/www.lmc.ca\/#\/schema\/person\/0d459c76f19eec906969bebe87612783","name":"\u0627\u06cc\u0644 \u0627\u06cc\u0645 \u0633\u06cc \u06c1\u06cc\u0644\u062a\u06be \u06a9\u06cc\u0626\u0631","image":{"@type":"ImageObject","inLanguage":"ur","@id":"https:\/\/secure.gravatar.com\/avatar\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g","caption":"LMC Healthcare"},"url":"https:\/\/www.lmc.ca\/ur\/author\/andrea\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/posts\/5350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/comments?post=5350"}],"version-history":[{"count":0,"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/posts\/5350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/media\/5352"}],"wp:attachment":[{"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/media?parent=5350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/categories?post=5350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lmc.ca\/ur\/wp-json\/wp\/v2\/tags?post=5350"}],"curies":[{"name":"\u0688\u0628\u0644\u06cc\u0648 \u067e\u06cc","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}